期刊文献+

维甲酸诱导基因G抑制肿瘤细胞增殖的分子机制研究 被引量:6

Molecular mechanism of the inhibitory effect of retinoic acid-induced gene G protein on tumor cell proliferation
原文传递
导出
摘要 目的探讨维甲酸诱导基因G(RIG—G)抑制肿瘤细胞增殖的分子机制。方法应用转染实验、Western印迹法、免疫共沉淀和免疫荧光共定位等技术验证RIG—G蛋白与JAB1蛋白之间的相互作用,并研究RIG—G蛋白对JAB1蛋白功能的影响。结果RIG—G蛋白可以与JAB1蛋白发生相互作用,并影响JAB1蛋白在细胞内的定位和分布。实验发现,在NIH3T3细胞中单独转染JAB1时,JAB1蛋白在细胞核和细胞质内呈弥散分布,而当与RIG—G共同转染后,JAB1蛋白在细胞核内的含量明显减少,而改变为主要在胞质内分布,并与RIG—G蛋白发生部分共定位。此外,RIG—G蛋白还具有抑制JAB1对细胞周期抑制因子p27的辅助降解功能。结论RIG—G可以通过和JAB1的相互作用,使后者部分滞留在细胞质内,从而影响JAB1发挥正常功能,干扰其对p27的辅助降解,维持细胞内p27的稳定性,促进细胞退出增殖周期,抑制细胞增殖。 Objective To investigate the molecular mechanisms of anti-proliferative effect of retinoic acid-induced gene G (RIG-G) protein on tumor cells. Methods HA- RIG-G expression plasmid and FLAG- Jun activating binding protein 1 (JAB1) expression plasmid were construction and transfected into the African green monkey kidney cells of the line CDS-7 and mouse fibroblast cells of the line NIH3T3. Western blotting was used to detect the p27 expression in the cells, analysis, and Immunofluorescence staining was used to examine the distribution of JAB1 protein. Coimmunoprecipitation was used to analyze the interference of RIG-G on the function of JAB1 protein. Results Coimmunoprecipitation showed that when HA-RIG-G and FLAG-JAB1 were co-expressed, the RIG-G protein and JAB1 protein could be coprecipitated by the antibodies of the other side. RIG-G was able to interact with JAB1 and alter its intracellular localization and distribution. When JAB1 was transfected alone into the NIH3T3 cells, it dispersed in both nucleus and cytoplasm; however, when RIG-G and JAB1 were cotransfected, the nuclear JAB1 was markedly diminished and exhibited a partly co-localization with RIG-G in the cytoplasm. Western blotting showed that along with the increase of the dose of transfected JAB1 the amount of p27 in the cell; and along with the increase of co-transfected RIG-G gene expression plasmid the amount of p27 in the cells re-increased. Conclusion RIG-G interacts with JAB1, thus resulting in JAB1 sequestration in the cytoplasm, disturbing the JAB1 normal function, interfering the JABl-mediated p27 degradation, maintaining p27 protein stability so as to prevent cells from entering the cycle and inhibiting cell proliferation.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第2期110-113,共4页 National Medical Journal of China
基金 国家自然科学基金资助项目(30570778,30670882) 国家“973”重点基础研究发展计划基金资助项目(2002CB512805) 中国高技术研究发展“863”计划基金资助项目(2006AA02219A) 上海市教委曙光计划基金资助项目(2003年) 上海交通大学医学院骨干师资计划(2003年)
关键词 肿瘤细胞 培养的 维甲酸 维甲酸诱导基因-G PrP27-30蛋白质 JAB1 Tumor cell,cultured Tretinoin Retinoic acid-induced gene G PrP27-30 protein JAB1
  • 相关文献

参考文献10

  • 1Fang J, Chen SJ, Tong JH, et al. Treatment of acute promyelocytic leukemia with ATRA and As203: a model of molecular target-based cancer therapy. Cancer Biol Ther, 2002, 1 : 614-620.
  • 2Yu M, Tong JH, Mao M, et al. Cloning of a gene (RIG-G) associated with retinoic acid-induced differentiation of acute promyelocytic leukemia cells and representing a new member of a family of interferon-stimulated genes. Proc Natl Acad Sci USA, 1997, 94: 7406-7411.
  • 3Xiao S, Li D, Zhu HQ, et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA, 2006, 103 : 16448-16453.
  • 4Naumann M, Bech-Otschir D, Huang X, et al. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J Biol Chem, 1999, 274 : 35297-35300.
  • 5Zhu Q, Zhang JW, Zhu HQ, et al. Synergic effects of arsenic trioxide and cAMP during acute promyelocytic leukemia cell maturation subtends a novel signaling cross-talk. Blood, 2002, 99: 1014-1022.
  • 6朱海青,王海红,陈赛娟,陈竺,王振义,童建华.酵母双杂交研究与RIG-G相互作用的蛋白[J].上海第二医科大学学报,2001,21(5):385-389. 被引量:2
  • 7Chamovitz DA, Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep, 2001, 2: 96-101.
  • 8Tomoda K, Kubota Y, Arata Y, et al. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem, 2002, 277: 2302-2310.
  • 9Blain SW, Scher HI, Cordon-Cardo C, et al. p27 as a target for cancer therapeutics. Cancer Cell, 2003, 3 : 111-115.
  • 10Moller MB. p27 in cell cycle control and cancer. Leuk. Lymphoma, 2000, 39:19-27.

二级参考文献3

  • 1Liu T X,Blood,2000年,96卷,1496页
  • 2Yu M,Proc Nat Acad Sci USA,1997年,94卷,7406页
  • 3Chung C D,Science,1997年,278卷,5344期,1803页

共引文献1

同被引文献46

  • 1Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 2008 ; 111 ( 5 ) : 2505 - 2515.
  • 2YuM, Tong JH, Mao M, et al. Cloning of a gene (RIG-G)associated with retinoic acid-induced differentiation of acute promyelocytic leukemia ceils and representing a new member of a family of interferon-stimulated genes. Proc Natl Acad Sci USA, 1997; 94 (14) : 7406 -7411.
  • 3Xiao S, Li D, Zhu HQ, et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA, 2006; 103(44) : 16448 - 16453.
  • 4Reich NC. STAT dynamics. Cytokine Growth Factor Rev, 2007 ; 18(5 -6): 511 -518.
  • 5Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol, 2006 ; 6 ( 9 ) : 644 - 658.
  • 6Bluyssen HA, Levy DE. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by statl and p48 for stable interaction with DNA. J Biol Chem, 1997; 272(7) : 4600 - 4605.
  • 7Martinez-Moczygemba M, Gutch MJ, French DL, et al. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3. J Biol Chem, 1997 ; 272 (32) : 20070 - 20076.
  • 8Jemal A,Siegel R, Xu J, et al. Cancer statistics, 2010 [ J ]. CA Cancer J Clin,2010 ,60 :277-300.
  • 9Filipits M, Rudas M, Heinzl H,et al. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor- positive breast cancer patients receiving adjuvant tamoxifen therapy [ J 1. Clin Cancer Res, 2009,15:5888-5894.
  • 10Chu IM,Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy [ J ]. Nat Rev Cancer,2008,8:253-267.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部